Natural Products as HIV Reverse Transcriptase Inhibitors [PDF]
, 2009 Fundação Oswaldo Cruz. Instituto de Tecnologia em Fármacos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Fármacos. Rio de Janeiro, RJ, BrasilFundação Oswaldo Cruz. Instituto de Tecnologia em Fármacos.
Gonçalves, R. S. B. +3 more
core
Fullerene Derivatives of Nucleoside HIV Reverse Transcriptase Inhibitors-In Silico Activity Prediction. [PDF]
Int J Mol Sci, 2018 Dąbrowska A +6 more
europepmc +1 more source
A highly sensitive aptamer-based HIV reverse transcriptase detection assay. [PDF]
J Virol Methods, 2018 DeStefano JJ, Alves Ferreira-Bravo I.
europepmc +1 more source
The impact of a UK HIV-1 resistance database for the management and improvement of the clinical care of people living with HIV-1 [PDF]
Background: The introduction of highly active antiretroviral therapies (HAART) in 1996 to treat patients living with the human immunodeficiency virus type 1 (HIV-1), led to dramatic improvements in their mortality and morbidity.
MacRae, Eilidh
core
Profiling the Interaction between Human Serum Albumin and Clinically Relevant HIV Reverse Transcriptase Inhibitors. [PDF]
VirusesCosta-Tuna A +5 more
europepmc +1 more source
Potent NLRP3 Inflammasome Activation by the HIV Reverse Transcriptase Inhibitor Abacavir. [PDF]
J Biol Chem, 2017 Toksoy A +6 more
europepmc +1 more source
Rate-limiting Pyrophosphate Release by HIV Reverse Transcriptase Improves Fidelity. [PDF]
J Biol Chem, 2016 Li A, Gong S, Johnson KA.
europepmc +1 more source
Effect of tRNA on the Maturation of HIV-1 Reverse Transcriptase. [PDF]
J Mol Biol, 2018 Ilina TV +5 more
europepmc +1 more source
HIV Reverse Transcriptase and Protease Genes Variability Can Be a Biomarker Associated with HIV and Hepatitis B or C Coinfection. [PDF]
Sci Rep, 2018 Cantão NM +9 more
europepmc +1 more source